Yunxiao Yang

Yunxiao Yang

Auto-generated profile, based on publicly available information

Yunxiao Yang

Department of Cardiology (L.L., Y.Y.), Beijing Anzhen Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Environmental Science & Technology
Verified
Journal Article
Closed access
YYYunxiao Yang
Yunxiao Yang
EXEnzehua Xie
Enzehua Xie
Zhiyong DuZhiyong Du
Zhiyong Du
ZPZhan Peng
Zhan Peng
ZHZhongyi Han
Zhongyi Han
XYXiubin Yang
Xiubin Yang

1 August 2020 in Atherosclerosis
Verified
Journal Article
Open access
XJXiaolu Jiao
Xiaolu Jiao
YYYunyun Yang
Yunyun Yang
LLLinyi Li
Linyi Li
HYHuahui Yu
Huahui Yu
YYYunxiao Yang
Yunxiao Yang
Yanwen QinYanwen Qin
Yanwen Qin
Angiopoietin-like protein 8 (ANGPTL8) is a hormone involved in regulating lipid metabolism. Patients with coronary artery disease have markedly higher plasma levels of ANGPTL8 than controls; however, the role of ANGPTL8 in atherosclerosis has not been explored. Therefore, we explored the effects of ANGPTL8 on atherosclerosis development in a mouse model. We induced experimental atherosclerosis in ApoE-/- mice ANGPTL8-knockdown. and ANGPTL8-overexpression ApoE-/- mice. We also explored the mechanism using ANGPTL8-overexpression macrophages. ANGPTL8 expression was increased in human and mouse atherosclerotic lesions. ANGPTL8 overexpression promoted the development of atherosclerosis whereas ANGPTL8 knockdown protected against atherosclerosis. Immunofluorescence co-staining results showed that ANGPTL8 was expressed in macrophages in atherosclerotic plaques. Compared with wild type cells, ANGPTL8-overexpressing macrophages, including bone marrow-derived macrophages and Raw 264.7 macrophages, showed enhanced foam cell formation and increased accumulation of cholesterol that was induced by increased uptake and decreased efflux of cholesterol. The results of this study also showed that ANGPTL8 induced the expression of CD36 and scavenger receptor (SR)-A, and inhibited the expression of SR-BI. Our findings demonstrate an unanticipated role of ANGPTL8 in the development of atherosclerosis and regulation of foam cell formation. ANGPTL8 may be a promising new target for atherosclerosis.

22 May 2026 in Circulation Research
Verified
Journal Article
Closed access
YPYilin Pan
Yilin Pan
LLLinqi Liu
Linqi Liu
JLJiyuan Luo
Jiyuan Luo
XZXiaozheng Zhou
Xiaozheng Zhou
YWYu Wang
Yu Wang
XYXiubin Yang
Xiubin Yang
BACKGROUND: Micro(nano)plastics (MNPs) are pervasive environmental contaminants, yet their presence in human cardiac tissue and their potential contribution to myocardial fibrosis remain unclear. We investigated whether myocardial MNP burden is associated with fibrosis severity in patients and evaluated mechanistic plausibility in mice. METHODS: Left atrial appendage tissues were collected from patients undergoing cardiac surgery (n=33). MNP burden and polymer composition were quantified by pyrolysis-gas chromatography/mass spectrometry, and fibrosis was quantified histologically. In mice, 100-nm or 1-µm polystyrene nanoplastics were administered by oral gavage in coexposure and sequential exposure protocols with isoprenaline. Cardiac function was assessed by echocardiography, and fibrosis was evaluated by histology and immunohistochemistry. Transcriptomics, metabolomics, and 16S ribosomal RNA sequencing were performed to identify pathways linked to MNP exposure. RESULTS: MNPs were detected in all human cardiac samples. Patients with high fibrosis exhibited higher total MNP levels than those with low fibrosis (171.74 [interquartile range [IQR], 158.18–202.39] versus 119.33 [IQR, 102.75–148.44] µg/g tissue; P =2.5×10 – 4 ), driven predominantly by elevated nanoplastics (122.83 [IQR, 100.10–149.06] versus 86.39 [IQR, 36.85–103.74] µg/g; P =0.010). Polystyrene and polyvinyl chloride were enriched in high-fibrosis tissues (polystyrene: P =3.3×10 – 4 ; polyvinyl chloride: P =0.002). Transcriptomics indicated activation of inflammatory and profibrotic pathways (TNF [tumor necrosis factor]/NF-κB [nuclear factor-κB], TGF-β [transforming growth factor-beta], and MAPK [mitogen-activated protein kinase]), supported by increased α-SMA (alpha-smooth muscle actin), COL1 (collagen I), and TGF-β1 immunostaining, while metabolomics suggested perturbations in lipid metabolism and mitochondrial function. In mice, polystyrene exposure exacerbated isoprenaline-induced systolic dysfunction and myocardial fibrosis in both experimental paradigms and recapitulated pathway signatures related to cell-matrix interactions. CONCLUSIONS: Myocardial MNP burden, particularly nanoplastics, is associated with greater fibrosis in humans, and experimental polystyrene exposure aggravates stress-induced myocardial remodeling in vivo. Multiomics analyses nominate inflammatory, ECM (extracellular matrix), and metabolic programs as candidate mediators of MNP-associated cardiotoxicity.

27 April 2024 in Interdisciplinary CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
YPYilin Pan
Yilin Pan
YLYuhua Liu
Yuhua Liu
ZPZhan Peng
Zhan Peng
YYYunxiao Yang
Yunxiao Yang
LLLinqi Liu
Linqi Liu
KHKun Hua
Kun Hua
This study aims to investigate the relationship between serum calcium (SC) levels and the incidence of postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass graft surgery. This retrospective, observational cohort study consecutively enrolled patients undergoing isolated coronary artery bypass grafting in Beijing Anzhen Hospital from January 2018 to December 2021. Patients with a previous history of atrial fibrillation or atrial flutter or requiring concomitant cardiac surgery were excluded. A logistic regression model was used to determine predictors of POAF. Multivariable adjustment, inverse probability of treatment weighting and propensity score matching were used to adjust for confounders. Moreover, we conducted univariable and multivariable logistic regression analyses on preoperative and postoperative SC and ionized SC levels. The analysis encompassed 12 293 patients. The POAF rate was significantly higher in patients with low SC level than those without (1379 [33.9%] vs 2375 [28.9%], P < 0.001). Low SC level was associated with an increased odds ratio of POAF (odds ratio [95% confidence interval]: 1.27 [1.18–1.37], P < 0.001). Inverse probability of treatment weighting and propensity score matching analyses confirmed the results. The increased POAF rate in low SC level group still existed among subgroup analysis based on different age, sex, body mass index, hypertension, hyperlipidaemia, CHA2DS2-VASc and magnesium. Low SC level indicates elevated POAF risk in patients undergoing isolated coronary artery bypass graft surgery even after the adjustment for age, sex, cardiovascular risk factors, echocardiographic parameters and laboratory markers.

2 November 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
ZPZhan Peng
Zhan Peng
FOFlorian Osmanaj
Florian Osmanaj
YYYunxiao Yang
Yunxiao Yang
KHKun Hua
Kun Hua
XYXiubin Yang
Xiubin Yang
Dapagliflozin has been widely used for the treatment of type 2 diabetes mellitus (T2DM) and heart failure (HF). However, data concerning the association between dapagliflozin and the recurrence of atrial fibrillation (AF), especially in patients following Cox-Maze IV (CMIV), are rare. We aim to explore the effect of dapagliflozin on the recurrence of AF after CMIV with and without T2DM or HF. The study of dapagliflozin evaluation in AF patients followed by CMIV (DETAIL-CMIV) is a prospective, double-blind, randomized, placebo-controlled trial. A total of 240 AF patients who have received the CMIV procedure will be randomized into the dapagliflozin group (10 mg/day, n = 120) and the placebo group (10 mg/day, n = 120) and treated for 3 months. The primary endpoint is any documented atrial tachyarrhythmia (AF, atrial flutter or atrial tachycardia) lasting 30 s following a blanking period of 3 months after CMIV. DETAIL-CMIV will determine whether the sodium-glucose cotransporter-2 inhibitor dapagliflozin, added to guideline-recommended post-operative AF therapies, safely reduces the recurrence rate of AF in patients with and without T2DM or HF.

4 May 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YYYunxiao Yang
Yunxiao Yang
EXEnzehua Xie
Enzehua Xie
YLYuhua Liu
Yuhua Liu
ZPZhan Peng
Zhan Peng
CYCuntao Yu
Cuntao Yu
XYXiubin Yang
Xiubin Yang